Zhou, Zhuolong https://orcid.org/0000-0003-1194-988X
Van der Jeught, Kevin https://orcid.org/0000-0002-4626-2343
Fang, Yuanzhang
Yu, Tao https://orcid.org/0000-0002-1903-7589
Li, Yujing
Ao, Zheng
Liu, Sheng
Zhang, Lu
Yang, Yang
Eyvani, Haniyeh
Cox, Mary L.
Wang, Xiyu
He, Xiaoming https://orcid.org/0000-0003-0125-6086
Ji, Guang
Schneider, Bryan P.
Guo, Feng https://orcid.org/0000-0001-9103-3235
Wan, Jun https://orcid.org/0000-0001-9286-6562
Zhang, Xinna https://orcid.org/0000-0003-4118-2245
Lu, Xiongbin https://orcid.org/0000-0002-7987-9825
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA206366)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA243023)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA206366)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA243023)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA203737)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA222251)
Article History
Received: 7 May 2020
Accepted: 7 September 2021
First Online: 1 November 2021
Change Date: 30 August 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41551-023-01096-0
Competing interests
: X.L. and X.Z. are the inventors on the US Provisional Patent Application (Serial No. 63/129,762) submitted by The Trustees of Indiana University for the organoid-based screen method and identified drugs in this study.